Blood lymphocytes in myeloma patients; high percentage of complement receptor bearing cells is accompanied by decreased anti-immunoglobulin (Ig) binding capacity.
D000888:Antibodies, Anti-Idiotypic / Q000276:immunology*; D002462:Cell Membrane / Q000276:immunology; D003165:Complement System Proteins / Q000276:immunology*; D005455:Fluorescent Antibody Technique; D006801:Humans; D007136:Immunoglobulins / Q000276:immunology; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology*; D009101:Multiple Myeloma / Q000276:immunology*; D009584:Nitrogen / Q000494:pharmacology; D011947:Receptors, Antigen, B-Cell / Q000276:immunology; D012397:Rosette Formation
D000888:Antibodies, Anti-Idiotypic; D007136:Immunoglobulins; D011947:Receptors, Antigen, B-Cell; D003165:Complement System Proteins; D009584:Nitrogen